About Index Trending news
Analyze
Pricing
Navitor Pharma

Navitor Pharma

Work at Navitor Pharma? Add yourself to this profile

Navitor Pharma

Novel Therapeutics Targeting the Central Regulator of Nutrient Signaling
Edit Profile
More info

Elsewhere

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co nuTonomy nuTonomy HubSpot HubSpot Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
18 Dec 2015
$33,000,000
Venture capital (Series B)
Atlas Venture, Polaris Partners, SR One, +4

Navitor Pharmaceuticals Announces $33 Million Series B Financing

businesswire
19 Jun 2014
$23,500,000
Venture capital (Series A)
Atlas Venture, Johnson & Johnson Development Corporation, Polaris Partners, +1